Lexington Medical, Inc.

From Wikitia
Jump to navigation Jump to search
Lexington Medical, Inc.
Private
IndustryMedical devices
Founded2013
Key people
Leon Amariglio (CEO)
WebsiteOfficial website

Lexington Medical is a privately held U.S. medical device company headquartered in Massachusetts that designs and manufactures surgical stapler devices intended for minimally invasive surgery.

Company History

Lexington Medical, Inc. was founded in 2013[1] by Leon Amariglio. In 2017, it received U.S. FDA 510(k) clearance for the AEON Endoscopic Stapler.[2] In 2021, Medical Product Outsourcing reported on the AEON stapler reaching its 10,000-surgery milestone, noting its clinical use in laparoscopic procedures.[3] In 2024, GlobalData reported sustained revenue growth from 2017-2023, supporting Lexington Medical's market presence in surgical stapling.[4] In 2024, the company received FDA clearance for the AEON Endoscopic Powered Stapler[5] as reported by Modern Healthcare which highlighted it among notable device clearances of the year.[6]

In April 2025, Lexington Medical secured a strategic growth investment from Ampersand Capital Partners, a private equity firm specializing in healthcare and life sciences.[7] In late 2025, Lexington Medical was awarded a $195,000 tax incentive from the Massachusetts Life Sciences Center to support the creation of new jobs at its headquarters.[8]

Clinical Use

AEON surgical staplers are intended to staple and cut tissue for resection, transection, and creation of anastomosis. Clinical performance has been evaluated in peer-reviewed studies examining intra and post-operative outcomes.[9][10][11] A first-in-man trial evaluating the AEON Powered Stapling System was presented in the British Journal of Surgery in 2024. The study assessed device safety, firing mechanism performance, and initial clinical outcomes, contributing to the body of evidence supporting AEON’s surgical utility.[12] In March 2025, the journal Innovations in Hepatopancreatobiliary Surgery published a detailed review of the AEON endovascular stapler alongside the LOTUS‑Bowa liver blade. The review highlighted AEON’s innovative design and reported outcomes, including a reduction in postoperative pancreatic fistula from 65% to 20% during distal pancreatectomy, along with enhanced staple-line hemostasis in comparison to Medtronic’s Endo GIA device.[13]

References

  1. ↑ "Lexington Medical, Inc. - Corporation Summary". Massachusetts Secretary of the Commonwealth. Retrieved 2025-07-02.
  2. ↑ "Premarket Notification 510(k) Summary - K171589". U.S. Food and Drug Administration. Retrieved 2025-07-02.
  3. ↑ Barbella, Michael (June 16, 2021). "Lexington Medical Reaches 10000 Surgery Milestone for its Endostapling Device". Medical Product Outsourcing. Retrieved November 25, 2025.
  4. ↑ "Lexington Medical Inc, United States Revenue". MedicalDevice-Network.com (GlobalData). June 16, 2021. Retrieved July 16, 2025.
  5. ↑ "Premarket Notification 510(k) Summary - K234039". U.S. Food and Drug Administration. Retrieved 2025-07-02.
  6. ↑ Kacik, Alex (June 28, 2024). "FDA clears 8 devices, including AI-driven surgical tools". Modern Healthcare. Retrieved July 17, 2025.
  7. ↑ Latham & Watkins LLP (April 21, 2025). "Latham Watkins Advises Lexington Medical in Investment by Ampersand Capital Partners". Retrieved November 25, 2025.
  8. ↑ Farnsworth, Elizabeth (December 10, 2025). "Massachusetts Life Sciences Center hands out \$5.6M in tax incentives". Medical Design & Development. Retrieved November 25, 2025.
  9. ↑ Raftopoulos, Yannis; Rajkumar, Shruthi; Davidson, Elana; Papasavas, Pavlos (2022). "Prospective Randomized Comparison of Linear Endostaplers During Laparoscopic Sleeve Gastrectomy". Obesity Surgery. 32 (10): 3472–3480. doi:10.1007/s11695-022-06240-4. PMID 35974292.
  10. ↑ Sheen, Aali J.; Bandyopadhyay, Samik; Baltatzis, Minas; Deshpande, Rahul; Jamdar, Saurabh; de Liguori Carino, Nicola (2023). "Preliminary experience in laparoscopic distal pancreatectomy using the AEON endovascular stapler". Frontiers in Oncology. 13: 1146646. doi:10.3389/fonc.2023.1146646. PMC 10130406. PMID 37124511.
  11. ↑ Redmann, James G.; Lavin, Thomas E.; French, Matthew S. (2020). "Improving Hemostasis in Sleeve Gastrectomy With Alternative Stapler". JSLS. 24 (4): e2020.00073. doi:10.4293/JSLS.2020.00073. PMC 7791089. PMID 33447003.
  12. ↑ "First-in-man experience using the AEON Powered Stapling System". British Journal of Surgery. 112 (Supplement_5): znaf036.042. 2024. Retrieved 2025-07-21.
  13. ↑ Sheen, Aali J.; Barrie, Jenifer; Stathakis, Panagiotis; Jamdar, Saurabh (March 2025). "Innovations in Hepatopancreatobiliary Surgery: A Review of LOTUS‑Bowa Liver Blade and AEON Endovascular Stapler". Innovations in Hepatopancreatobiliary Surgery. 5 (2025): 6–12. doi:10.36401/ISIM-24-02. Retrieved 2025-07-21.

External links

Add External links

This article "Lexington Medical, Inc." is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.

Retrieved from "https://wikitia.com/index.php?title=Lexington_Medical,_Inc.&oldid=221815"